Notice Concerning Change in Subsidiary
Filed with TSE · · 2 pages · English
Watch Terumo's latest callTerumo (Tokyo:4543) Q1 2027 Earnings Call · Replay · Aug 7Read the transcript of Terumo (Tokyo:4543) Q1 2027 Earnings CallEarlier from Terumo
- Consolidated Financial Results for the Three Months Ended June 30, 2026〔IFRS〕
- Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
- Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration
- Terumo Announces Voluntary Recall of Specific Models of the Relay™Pro Thoracic Stent-Graft System in Global Markets
- Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States
Later from Terumo
- Terumo Neuro Announces Two WISE Study Publications Reporting 0% New Bleeds or Rebleeds Through One Year Following WEB™ Treatment in Ruptured and Unruptured Aneurysm Cohorts
- 6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®
- Notice Concerning Recognition of Losses Resulting from the Termination of a Supply Agreement with a Major Customer and the Revision of Consolidated Fi
- Decision Regarding the Termination of the Supply Agreement with CSL Plasma (with note)
- Terumo and the University of Oxford launch six-year partnership to advance organ perfusion technologies
Follow Terumo into a list and get an email when it puts out news.
Follow Terumo